Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia

J Egypt Natl Canc Inst. 2024 Feb 12;36(1):5. doi: 10.1186/s43046-024-00209-3.

Abstract

Objective: This study aimed to address the prognostic impact of SOX2 and OCT3/4 expression on adult acute leukemia patients' outcomes.

Methods: SOX2 and OCT3/4 expression by blast cells were evaluated by flow cytometry in 80 acute leukemia patients and 8 healthy controls.

Results: Baseline SOX2 and OCT3/4 expression were significantly higher in both ALL (P = < 0.001, P = 0.005 respectively) and AML patients (P < 0.001, P = 0.003 respectively) as compared to control, and decline at complete remission (CR) and elevated again at relapse. High SOX2 and OCT3/4 levels were significantly correlated with the presence of adverse risk stratification parameters.

Conclusion: Our findings indicated that both SOX2 and OCT3/4 could serve as biomarkers that could improve risk stratification of acute leukemia patients. Also, both SOX2 and OCT3/4 might be a therapeutic target, especially in resistant acute leukemia.

Keywords: ALL; AML; OCT3/4; Outcome; SOX2.

MeSH terms

  • Adult
  • Humans
  • Leukemia, Myeloid, Acute* / diagnosis
  • Prognosis
  • SOXB1 Transcription Factors / genetics

Substances

  • SOX2 protein, human
  • SOXB1 Transcription Factors